Newswise — BOSTON – Dana-Farber Cancer Institute is expanding its research footprint, occupying portions of five floors at Longwood Center, 360 Longwood Avenue, beginning later this month.
The new facility will be home to Dana-Farber’s chemical biology, structural biology and proteomics programs, as well as the Belfer Institute for Applied Cancer Science. A significant portion of Dana-Farber’s basic discovery research will be conducted there, as will a large component of the Experimental Therapeutics program with a focus on translational research in lung cancer.
The laboratories in Longwood Center were specifically designed with open spaces and are organized by neighborhoods to foster collaboration, creativity and productivity while optimizing natural light and views and operational efficiency.
“Longwood Center provides Dana-Farber with an unprecedented opportunity to reorganize our campus to accelerate the application of basic discovery and translational science into treatments that can improve the lives of cancer patients and families,” said Barrett Rollins, MD, PhD, chief scientific officer at Dana-Farber. “We will use this space to expand our chemical biology programs, which are the cornerstone of our new cancer therapeutics initiatives.”
Dana-Farber is the major tenant in Longwood Center, occupying 155,000 square feet with a 15-year lease including an option to renew. The building is owned jointly by Clarion, Alexandria and National Development.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, is world-renowned for its leadership in adult and pediatric cancer treatment and research. Designated as a comprehensive cancer center by the National Cancer Institute (NCI), it is one of the largest recipients among independent hospitals of NCI and National Institutes of Health grant funding. For more information, go to www.dana-farber.org.
# # #
RSS